Oct 29 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand for its generic drugs and ...

North Carolina is a leading place for biotech, and a big part of that success comes from GlaxoSmithKline (GSK). This global healthcare company has made a huge difference in the biotech scene here, ...

Amphetamine- and methylphenidate-based drugs are the first-choice medications used for treating many people with attention deficit hyperactivity disorder (ADHD). They are available in a generic ...

Dexedrine scored higher at 8.6/10 but with fewer total ratings. For some people, Dexedrine’s pure dextroamphetamine formulation works best. Others find Adderall’s blend more helpful for focus ...

Hindustan Unilever Ltd (HUL) has filed an appeal with the Commissioner of Income Tax, challenging a Rs 962.75 crore tax demand related to its acquisition of the Horlicks brand from ...

Moderna to defend against GSK's claims, spokesperson says GSK seeks unspecified monetary damages from Moderna A spokesperson for Massachusetts-based Moderna said the company was aware of the ...

(Reuters) -British drugmaker GlaxoSmithKline (NYSE:GSK) sued Moderna (NASDAQ:MRNA) in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK patent rights in messenger RNA ...

(Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK patent rights in messenger RNA technology with its blockbuster ...

Attention-deficit hyperactivity disorder (ADHD) medications are prescribed to manage common ADHD symptoms, like difficulty focusing, impulsiveness, and hyperactivity. Medications approved to treat ...